From: Implementation of a fetal ultrasound telemedicine service: women’s views and family costs
Primary Indication | Sub-group indication | Phase 1 number of new referrals | Phase 1 number of follow-up appointments | Phase 2 number of new referral appointments | Phase 2 number of follow-up appointments |
---|---|---|---|---|---|
Suspected fetal anomaly | Renal, urinary & genitalia | 5 | 2 | 18 | 9 |
Central nervous system | 6 | 4 | 6 | 5 | |
Heart arrhythmia | 1 | 0 | 1 | 2 | |
Musculoskeletal | 0 | 0 | 7 | 0 | |
Thorax and diaphragm | 0 | 0 | 1 | 8 | |
Abdominal wall and gastrointestinal | 3 | 4 | 9 | 0 | |
Tumour | 0 | 0 | 1 | 2 | |
Small-for-gestational age | Singleton | 4 | 17 | 8 | 23 |
Multiple pregnancy | Twin-to-twin transfusion syndrome screening and management | 3 | 1 | 1 | 5 |
Small-for-gestational age | 0 | 0 | 3 | 2 | |
Combined testing | 2 | 0 | 22 | 0 | |
Other e.g. single demise | 0 | 0 | 1 | 2 | |
Placenta | Abnormally invasive placenta screening and management | 11 | 3 | 15 | 4 |
Praevia and other (e.g. antepartum haemorrhage) | 1 | 0 | 10 | 8 | |
Amniotic fluid | Oligo/anhydramnios | 0 | 0 | 1 | 1 |
Preterm premature rupture of membranes | 1 | 1 | 0 | 0 | |
Fetal infection | 0 | 0 | 6 | 15 | |
Combined testing | High risk result | 0 | 0 | 1 | 0 |
Alloimmunisation | 1 | 8 | 1 | 13 | |
Previous history | Structural or genetic anomaly | 2 | 0 | 2 | 6 |
Total | 40 | 40 | 114 | 103 |